Reify Health
Founded Year
2012Stage
Series D | AliveTotal Raised
$477.64MValuation
$0000Last Raised
$220M | 2 mos agoAbout Reify Health
Reify Health provides cloud-based software that accelerates the development of new and life-saving therapies. Reify Health aims to change how clinical trials are run through its StudyTeam and Care Access platforms. StudyTeam delivers a technology platform for optimizing patient recruitment and enrollment. Care Access, which conducts decentralized trials at scale, is a decentralized research organization that aims to bring clinical trial infrastructure directly to patients, healthcare providers, and communities. Reify Health was founded in 2012 and is based in Boston, Massachusetts.
Reify Health Headquarter Location
33 Arch Street 17th Floor
Boston, Massachusetts, 02110,
United States
ESPs containing Reify Health
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
Companies in this market raise awareness of clinical trial opportunities and offer software that streamlines patient enrollment into a clinical trial. Solutions leverage varied approaches for finding patients, from AI for electronic health record (EHR) data to building disease-specific patient communities.
Reify Health named as Highflier among 15 other companies, including Deep Lens, Elligo Health Research, and TrialJectory.
Research containing Reify Health
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Reify Health in 3 CB Insights research briefs, most recently on May 9, 2022.
Expert Collections containing Reify Health
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Reify Health is included in 6 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,163 items
Clinical Trials Tech
326 items
Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.
Digital Health
12,999 items
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Clinical Trials Tech Market Map
108 items
This CB Insights Tech Market Map highlights 100+ clinical trials tech companies that are addressing 8 distinct technology priorities that pharmaceutical companies and CROs face.
Digital Health 150
150 items
The winners of the third annual CB Insights Digital Health 150.
Biopharma Tech
326 items
Reify Health Patents
Reify Health has filed 2 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/6/2010 | 4/7/2015 | Fractals, Dynamical systems, Chemical processes, Systems theory, Robotics | Grant |
Application Date | 1/6/2010 |
|---|---|
Grant Date | 4/7/2015 |
Title | |
Related Topics | Fractals, Dynamical systems, Chemical processes, Systems theory, Robotics |
Status | Grant |
Latest Reify Health News
May 26, 2022
The London-based company most recently raised £5 million in Series A funding in 2020. Photo: uMotif Patient data capture and clinical trial tech company uMotif announced Wednesday it had secured $25.5 million from a fund managed by Athyrium Capital Management. WHAT IT DOEs uMotif makes software for gathering patient data for clinical trials and research, including decentralized studies. Its offerings include tools for obtaining consent, for electronic clinical outcome assessments (eCOA), for electronic patient-reported outcomes (ePRO) and eDiaries, and for capturing symptom information and wearable data. WHAT IT'S FOR The company will use the capital to scale and develop its platform and continue its international expansion. uMotif said it's currently used in 30 countries, and is particularly focused on growing its team in North America, including in sales, marketing and service delivery. "We are delighted to welcome Athyrium to support our journey to be the most patient-centric platform for research. I truly believe that clinical research must put patients first, delivering more engaging research studies. With this investment from Athyrium I'm excited to grow our global capabilities to better serve our sponsors, partners and – most importantly – the patients we help take part in research," CEO Steve Rosenberg said in a statement. MARKET SNAPSHOT In the wake of the COVID-19 pandemic that pushed many researchers to adapt to decentralized trials , a number of startups are raising funds for clinical trial technology. In April, Reify Health raised $220 million in Series D funding , boosting its valuation to nearly $5 billion. It offers software for study sites and sponsors to assist in recruiting, pre-screening and enrolling patients in clinical trials. Reify also provides traveling research staff and delivers supplies to set up sites. Another company that focuses on decentralized trials is Curebase, which recently raised $40 million in Series B funding . The startup's tools include an app to help patients enroll, sign consent forms and access telehealth and home visits. DCT company THREAD is also expanding its patient engagement tools. In April, it announced it had acquired CureClick , a platform for recruiting trial participants. Meanwhile, YPrime, a cloud-based clinical trial data management tool, revealed plans to buy Tryl , a platform that provides support to patients so they don't drop out of trials, in February. Tags:
Reify Health Web Traffic
Reify Health Rank
When was Reify Health founded?
Reify Health was founded in 2012.
Where is Reify Health's headquarters?
Reify Health's headquarters is located at 33 Arch Street, Boston.
What is Reify Health's latest funding round?
Reify Health's latest funding round is Series D.
How much did Reify Health raise?
Reify Health raised a total of $477.64M.
Who are the investors of Reify Health?
Investors of Reify Health include Battery Ventures, Coatue Management, Adams Street Partners, Altimeter Capital, Dragoneer Investment Group and 8 more.
Who are Reify Health's competitors?
Competitors of Reify Health include Curebase and 7 more.
You May Also Like
Medable is a decentralized clinical trial software company. The company's Software-as-a-Service (SaaS) cloud platform aims to provide a path to secure, HIPAA-compliant healthcare applications for researchers, startups, pharma, payers, and academia. This platform allows for supporting patient engagement clinical applications, storing personal health information, and complying with HIPAA and other regulations. Medable aims to enable patient-generated data to drive clinical research, healthcare delivery, and personalized and predictive medicine.
Curebase runs clinical trials via software that reduces recruitment times, automates manual steps, and lets drug companies distribute their trials to clinics. Curebase was founded in 2017 and is based in San Francisco, California.
THREAD is a virtual research platform used by biopharma, CROs, non-profit researchers, and life science organizations to capture global clinical study data in between, as well as during and instead of clinic visits.
Hawthorne Effect uses a technology platform and trained freelance healthcare investigators (dubbed HEROs) to help improve clinical trial data quality by helping to prevent patient withdrawals and improve data collection and patient satisfaction rates.
ObvioHealth develops ClaimIt, a proprietary digital platform that utilizes a 100% online and mobile app interface to execute clinical trials. ClaimIt removes the costly overhead of physical site visits and brings the trial directly to the mobile device of each subject.
TrialSpark is a clinical trial management software and drug development company. The company aims to accelerate the pace of clinical trials and bring down costs with a software platform that helps sites like hospitals manage trials and collect and analyze data. Per the company, it uses data from social media to find doctors and patients to participate.While it began as a clinical trial technology platform, in 2021, it signaled a move to using its technology for drug development through the acquisition of biologic and small-molecule drugs. TrialSpark began primarily as a technology company that aims to bring treatments to patients faster using technology that improves clinical trials and drug development. TrialSpark has scaled a network of trial sites by partnering with doctors to create clinical trial sites within their existing practices. TrialSpark runs trials out of these doctor practices using a roaming cohort of certified research coordinators, optimized by software, data, and technology. Without variability in operations at the trial site level, TrialSpark cuts out the manual, time-intensive, and costly tasks that delay clinical trial timelines. By creating trial sites with doctors, TrialSpark unlocks the 98 percent of patients who have never been exposed to trials, boosting recruitment and enrollment rates and democratizing access.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.